A new class of CRISPR-based tools efficiently corrects point mutations in cell lines, animal models and perhaps the clinic. When Xingxu Huang began thinking about correcting disease-causing mutations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results